Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fraser Wright

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Research and Practice in Thrombosis and Haemostasis|September 6, 2021
The intersection of vector biology, gene therapy, and hemophiliaLeszek Lisowski, Janice M Staber, J Fraser Wright, et al.
Cytotherapy|March 1, 2022
Design of experiments as a decision tool for cell therapy manufacturingEsmond Lee, Devin Shah, Matthew Porteus, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 23, 2009
Translational nanomedicine: status assessment and opportunitiesJames S Murday, Richard W Siegel, Judith Stein, et al.
Human Gene Therapy|August 10, 2004
Infectious titer assay for adeno-associated virus vectors with sensitivity sufficient to detect single infectious eventsZhu Zen, Yero Espinoza, Thieu Bleu, et al.
International Journal of Toxicology|November 2, 2020
Safety Assessment of AAV2-hGDNF Administered Via Intracerebral Injection in Rats for Treatment of Parkinson's DiseasePramod S Terse, Adrian P Kells, Patricia Noker, et al.
Journal of Virological Methods|February 8, 2011
PEG-modulated column chromatography for purification of recombinant adeno-associated virus serotype 9Jingmin Zhou, Xiao Yang, J Fraser Wright, et al.
Molecular Therapy. Methods & Clinical Development|June 4, 2020
Timing of Intensive Immunosuppression Impacts Risk of Transgene Antibodies after AAV Gene Therapy in Nonhuman PrimatesBenjamin J Samelson-Jones, Jonathan D Finn, Patricia Favaro, et al.
Blood|March 22, 2013
AAV-mediated expression of an ADAMTS13 variant prevents shigatoxin-induced thrombotic thrombocytopenic purpuraSheng-Yu Jin, Juan Xiao, Jialing Bao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2012
Cerebral infusion of AAV9 vector-encoding non-self proteins can elicit cell-mediated immune responsesAgnieszka Ciesielska, Piotr Hadaczek, Gabriele Mittermeyer, et al.
Human Gene Therapy|December 4, 2010
Safety of liver gene transfer following peripheral intravascular delivery of adeno-associated virus (AAV)-5 and AAV-6 in a large animal modelPatricia Favaro, Jonathan D Finn, Joshua I Siner, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Research and Practice in Thrombosis and Haemostasis|September 6, 2021
The intersection of vector biology, gene therapy, and hemophiliaLeszek Lisowski, Janice M Staber, J Fraser Wright, et al.
Cytotherapy|March 1, 2022
Design of experiments as a decision tool for cell therapy manufacturingEsmond Lee, Devin Shah, Matthew Porteus, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 23, 2009
Translational nanomedicine: status assessment and opportunitiesJames S Murday, Richard W Siegel, Judith Stein, et al.
Human Gene Therapy|August 10, 2004
Infectious titer assay for adeno-associated virus vectors with sensitivity sufficient to detect single infectious eventsZhu Zen, Yero Espinoza, Thieu Bleu, et al.
International Journal of Toxicology|November 2, 2020
Safety Assessment of AAV2-hGDNF Administered Via Intracerebral Injection in Rats for Treatment of Parkinson's DiseasePramod S Terse, Adrian P Kells, Patricia Noker, et al.
Journal of Virological Methods|February 8, 2011
PEG-modulated column chromatography for purification of recombinant adeno-associated virus serotype 9Jingmin Zhou, Xiao Yang, J Fraser Wright, et al.
Molecular Therapy. Methods & Clinical Development|June 4, 2020
Timing of Intensive Immunosuppression Impacts Risk of Transgene Antibodies after AAV Gene Therapy in Nonhuman PrimatesBenjamin J Samelson-Jones, Jonathan D Finn, Patricia Favaro, et al.
Blood|March 22, 2013
AAV-mediated expression of an ADAMTS13 variant prevents shigatoxin-induced thrombotic thrombocytopenic purpuraSheng-Yu Jin, Juan Xiao, Jialing Bao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2012
Cerebral infusion of AAV9 vector-encoding non-self proteins can elicit cell-mediated immune responsesAgnieszka Ciesielska, Piotr Hadaczek, Gabriele Mittermeyer, et al.
Human Gene Therapy|December 4, 2010
Safety of liver gene transfer following peripheral intravascular delivery of adeno-associated virus (AAV)-5 and AAV-6 in a large animal modelPatricia Favaro, Jonathan D Finn, Joshua I Siner, et al.
Pageof 7